Le Lézard
Classified in: Science and technology
Subject: PDT

evaluagentCX helps contact centers ditch unreliable customer surveys with AI-powered NPS


evaluagent invites product testers for incoming feature, xNPS (Expected Net Promoter Score)

MIDDLESBOROUGH, United Kingdom, April 24, 2024 /PRNewswire-PRWeb/ -- evaluagent, a global leader in contact center quality assurance and performance improvement software, is pleased to announce a leading-edge new feature coming to its award-winning platform evaluagentCX.

xNPS (Expected Net Promoter Score) has been designed to replace post-contact surveys with a generative AI-based result from every interaction. Requiring no historical data to get up and running, xNPS sets out to help contact centers achieve deeper, more accurate insights.

xNPS (Expected Net Promoter Score) has been designed to replace post-contact surveys with a generative AI-based result from every interaction. Requiring no historical data to get up and running, xNPS sets out to help contact centers achieve deeper, more accurate insights ? waving goodbye to an average survey response rate of 3% and instead, generating a score from 100% of interactions.

Enabled with seamless one-click activation, xNPS is evaluagent's first step on the journey to predictive analytics. This development paves the way to connect NPS ratings, along with other metrics and insights, to the automated QA workflows that surface must-monitor customer conversations.

Further to highly positive in-house testing, evaluagent's Product team will be getting evaluagentCX users testing the feature as part of an early access program.

Nadine Edmondson, Director of Product Marketing and GTM says: "The development of xNPS means evaluagentCX users will get a far more representative view of customers' feelings, beyond individual agents' performance. They won't be limited to a small sample size of their audience anymore, enabling them to make more informed decisions, understand the pitfalls and opportunities, and use the analysis to drive positive impact across the business. We're very excited about the potential of this feature and how these scores can then be connected to other insights within the platform, ultimately elevating our clients' understanding of their customer experience."

The xNPS early access program is available to join for evaluagentCX users now. Learn more about the feature and sign up for beta testing on evaluagent's Knowledge Hub.

Media Contact

Nicola Kirby, evaluagent, 44 0000000000, [email protected], https://www.evaluagent.com 

SOURCE evaluagent


These press releases may also interest you

at 13:20
Garrett Smith, Founder and CEO of Community Capital Technology Inc. ("Community Capital"), will be attending the Milken Institute Global Conference ("MI Global") May 5-8, 2024 in Los Angeles. The event brings together global executives and...

at 13:16
Quarterhill Inc. ("Quarterhill" or the "Company") , a leading provider of tolling and enforcement solutions in the Intelligent Transportation System ("ITS")...

at 12:25
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from the first and largest real-world patient cohort review...

at 09:05
Smart Meter, the leading supplier of Cellular Remote Patient Monitoring (RPM)tm solutions, has introduced a new version of the iGlucose, its patented cellular-connected glucose meter used by over 200,000 people with diabetes since 2019. The...

at 09:05
F5 announced that it has been singled out as a visionary in API security for its F5 Distributed Cloud Web App and API Protection (WAAP) in Enterprise Management Associates' Vendor Vision 2024 report. The report highlights "must see" security...

at 08:05
GE HealthCare today unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, which have been restricted by the performance limitations of conventional whole-body MR...



News published on and distributed by: